Search Legislation

Commission Decision of 23 November 2010 approving annual and multiannual programmes and the financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2011 and following years (notified under document C(2010) 8125) (2010/712/EU)

 Help about what version

What Version

More Resources

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Status:

This is the original version (as it was originally adopted).

Article 4Bluetongue in endemic or high risk areas

1.The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Latvia, Lithuania, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland and Sweden are hereby approved for the period from 1 January 2011 to 31 December 2011.

2.The financial contribution by the Union:

(a)

shall include a lump sum of EUR 0,5 per domestic animal sampled;

(b)

shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for:

(i)

the cost of carrying out the vaccination;

(ii)

the cost of carrying out laboratory tests for virological, serological and entomological surveillance;

(iii)

the purchase of traps and vaccines; and

(c)

shall not exceed the following:

(i)

EUR 390 000 for Belgium;

(ii)

EUR 10 000 for Bulgaria;

(iii)

EUR 1 500 000 for the Czech Republic;

(iv)

EUR 40 000 for Denmark;

(v)

EUR 400 000 for Germany;

(vi)

EUR 10 000 for Estonia;

(vii)

EUR 10 000 for Ireland;

(viii)

EUR 100 000 for Greece;

(ix)

EUR 7 000 000 for Spain;

(x)

EUR 3 000 000 for France;

(xi)

EUR 300 000 for Italy;

(xii)

EUR 50 000 for Latvia;

(xiii)

EUR 40 000 for Lithuania;

(xiv)

EUR 170 000 for Hungary;

(xv)

EUR 10 000 for Malta;

(xvi)

EUR 40 000 for the Netherlands;

(xvii)

EUR 360 000 for Austria;

(xviii)

EUR 50 000 for Poland;

(xix)

EUR 2 200 000 for Portugal;

(xx)

EUR 100 000 for Romania;

(xxi)

EUR 250 000 for Slovenia;

(xxii)

EUR 50 000 for Slovakia;

(xxiii)

EUR 20 000 for Finland;

(xxiv)

EUR 100 000 for Sweden.

3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for an ELISA test

:

EUR 2,5 per test;

(b) for a PCR test

:

EUR 10 per test;

(c) for the purchase of monovalent vaccines

:

EUR 0,3 per dose;

(d) for the purchase of bivalent vaccines

:

EUR 0,45 per dose;

(e) for the administration of vaccines to bovine animals

:

EUR 1,50 per bovine animal vaccinated, regardless of the number and types of doses used;

(f) for the administration of vaccines to ovine or caprine animals

:

EUR 0,75 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources